1 – 3 of 3
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effects of Recombinant α1-Microglobulin on Early Proteomic Response in Risk Organs after Exposure to 177Lu-Octreotate
Ytterbrink, Charlotte ; Shubbar, Emman ; Parris, Toshima Z. ; Langen, Britta ; Druid, Malin ; Schüler, Emil ; Strand, Sven Erik LU ; Åkerström, Bo LU ; Gram, Magnus LU
and Helou, Khalil
, et al.
(2024)
In International Journal of Molecular Sciences
25(13).
- Contribution to journal › Article
- 2023
-
Mark
Co-administration with A1M does not influence apoptotic response of 177Lu-octreotate in GOT1 neuroendocrine tumors
Rassol, Nishte ; Andersson, Charlotte ; Pettersson, Daniella ; Al-Awar, Amin ; Shubbar, Emman ; Kovács, Anikó ; Åkerström, Bo LU ; Gram, Magnus LU
; Helou, Khalil
and Forssell-Aronsson, Eva
(2023)
In Scientific Reports
13(1).
- Contribution to journal › Article
- 2019
-
Mark
Recombinant alpha-1-microglobulin is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumors
Andersson, Charlotte ; Shubbar, Emman ; Schuler, Emil ; Åkerström, Bo LU ; Gram, Magnus LU
and Forssell-Aronsson, Eva
(2019)
In Journal of Nuclear Medicine
60(11).
p.1600-1604
- Contribution to journal › Article